You have 9 free searches left this month | for more free features.

CLL

Showing 1 - 25 of 1,319

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

Not yet recruiting
  • CLL/SLL
  • lisaftoclax +BTK inhibitor
  • BTK inhibitor
  • (no location specified)
Oct 26, 2023

CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

Not yet recruiting
  • CLL/SLL
  • Orelabrutinib and BG
  • Wuhan, Hubei, China
  • +1 more
Jun 15, 2023

Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Questionnaires
  • Fit Bit
  • Houston, Texas
    M D Anderson Cancer Center
May 18, 2023

Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

Not yet recruiting
  • Autoimmune Hemolytic Anemia
  • +3 more
  • Ibrutinib 420 mg
  • (no location specified)
Jan 12, 2023

Orelabrutinib in the Treatment of CLL/SLL

Not yet recruiting
  • CLL/SLL
    • (no location specified)
    Jul 26, 2023

    Study of the Metabolism in the Lymphatic Niche of CLL

    Recruiting
    • CLL
    • NO intervention
    • Nice, France
      Nice University Hospital
    Nov 2, 2022

    CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

    Terminated
    • CLL
    • SLL
    • Boston, Massachusetts
    • +1 more
    Jan 30, 2023

    CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

    Not yet recruiting
    • CLL
    • (no location specified)
    Oct 3, 2023

    Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Observation
    • (no location specified)
    Oct 12, 2023

    AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)

    Recruiting
    • AML, Adult
    • CLL1 CAR-NK cell injection
    • Hangzhou, Zhejiang, China
      Clinical research ethics committee of the first affiliated hospi
    Aug 30, 2023

    Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

    Completed
    • Leukemia, Chronic Lymphatic
    • Stuttgart, Baden-Wuerttemberg, Germany
    • +4 more
    Nov 24, 2022

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • (no location specified)
    Nov 9, 2023

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • 5:2 Method (intermittent fasting regimen)
    • 16/8 Method (intermittent fast regimen)
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Feb 2, 2023

    Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • CLL1/+CD33 CAR-T
    • Fuzhou, Fujian, China
      Fujian Provincial Children's Hospital
    Jul 10, 2023

    Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

    Recruiting
    • Acute Myeloid Leukemia
    • CLL1 and CD38 dual-target CAR-T injection
    • Kunming, Yunnan, China
      920th Hospital of Joint LogisticsSupport Force of People's Liber
    Oct 26, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • TQB3909 tablet
    • Zhengzhou, Henan, China
    • +1 more
    Jul 17, 2023

    Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

    Active, not recruiting
    • Chronic Lymphocytic Leucemia
    • Cologne, Germany
      German CLL Study Group
    Sep 14, 2022

    Chronic Lymphocytic Leukemia Trial in Russian Federation

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Irkutsk, Russian Federation
      • +5 more
      Jan 17, 2023

      CLL/SLL Trial in Beijing (orelabrutinib)

      Recruiting
      • CLL/SLL
      • Beijing, Beijing, China
      • +1 more
      Aug 5, 2022

      Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
      • +2 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Jan 20, 2023

      Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

      Terminated
      • Chronic Lymphocytic Leukemia(CLL)
      • Small Lymphocytic Lymphoma
      • Hackensack, New Jersey
        Hackensack University Medical Center
      Jun 24, 2022

      CLL/SLL Trial in Worldwide (Epcoritamab, Venetoclax)

      Not yet recruiting
      • CLL/SLL
      • Antwerpen, Belgium
      • +23 more
      Mar 28, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Dec 5, 2022

      Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Granada, Spain
        • +4 more
        Nov 8, 2023

        Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

        Recruiting
        • Relapsed or Refractory CD19+ B-cell Lymphoma
        • +2 more
        • TBI-2001
        • +2 more
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jul 26, 2023